Core labeling of adenovirus with EGFP

Virology

Volumn 351, Issue 2, 2006, Pages 291-302

  Le, Long P ^a   Le, Helen N ^a   Nelson, Amy R ^a   Matthews, David A ^b   Yamamoto, Masato ^a   Curiel, David T ^a  

^a University of Alabama at Birmingham   (United States)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adenovirus; Core proteins; EGFP; Fluorescent labeling; Gene therapy; Mu; V; Vector; VII

Indexed keywords

CHIMERIC PROTEIN; CORE PROTEIN; ENHANCED GREEN FLUORESCENT PROTEIN; VIRUS DNA;

ADENOVIRUS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CYTOPATHOGENIC EFFECT; DNA REPLICATION; EMBRYO; FLUORESCENCE; FUSION GENE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; THERMOSTABILITY; VIRUS DETECTION; VIRUS GENE; VIRUS INFECTION; VIRUS PURIFICATION;

ADENOVIRIDAE; ANIMALS; CELL LINE; CRICETINAE; GENE EXPRESSION; GREEN FLUORESCENT PROTEINS; HUMANS; RECOMBINANT PROTEINS; STAINING AND LABELING; VIRAL CORE PROTEINS;

ADENOVIRIDAE;

EID: 33746321306     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.03.042     Document Type: Article

References (46)

1. Alemany R., Suzuki K., and Curiel D.T. Blood clearance rates of adenovirus type 5 in mice. J. Gen. Virol. 81 Pt. 11 (2000) 2605-2609
2. Alestrom P., Akusjarvi G., Lager M., Yeh-kai L., and Pettersson U. Genes encoding the core proteins of adenovirus type 2. J. Biol. Chem. 259 22 (1984) 13980-13985
3. Anderson C.W., Young M.E., and Flint S.J. Characterization of the adenovirus 2 virion protein, mu. Virology 172 2 (1989) 506-512
4. Berk A.J. Adenovirus promoters and E1A transactivation. Annu. Rev. Genet. 20 (1986) 45-79
5. Berkner K.L., and Sharp P.A. Effect of the tripartite leader on synthesis of a non-viral protein in an adenovirus 5 recombinant. Nucleic Acids Res. 13 3 (1985) 841-857
6. Bernt K.M., Ni S., Li Z.Y., Shayakhmetov D.M., and Lieber A. The effect of sequestration by nontarget tissues on anti-tumor efficacy of systemically applied, conditionally replicating adenovirus vectors. Mol. Ther. 8 5 (2003) 746-755
7. Cai F., and Weber J.M. Primary structure of the canine adenovirus PVII protein: functional implications. Virology 193 2 (1993) 986-988
8. Chatterjee P.K., Vayda M.E., and Flint S.J. Interactions among the three adenovirus core proteins. J. Virol. 55 2 (1985) 379-386
9. Chatterjee P.K., Vayda M.E., and Flint S.J. Identification of proteins and protein domains that contact DNA within adenovirus nucleoprotein cores by ultraviolet light crosslinking of oligonucleotides 32P-labelled in vivo. J. Mol. Biol. 188 1 (1986) 23-37
10. Chow L.T., Gelinas R.E., Broker T.R., and Roberts R.J. An amazing sequence arrangement at the 5′ ends of adenovirus 2 messenger RNA. Cell 12 1 (1977) 1-8
11. Dmitriev I.P., Kashentseva E.A., and Curiel D.T. Engineering of adenovirus vectors containing heterologous peptide sequences in the C terminus of capsid protein IX. J. Virol. 76 14 (2002) 6893-6899
12. Fallaux F.J., Kranenburg O., Cramer S.J., Houweling A., Van Ormondt H., Hoeben R.C., and Van Der Eb A.J. Characterization of 911: a new helper cell line for the titration and propagation of early region 1-deleted adenoviral vectors. Hum. Gene Ther. 7 2 (1996) 215-222
13. Glotzer J.B., Michou A.I., Baker A., Saltik M., and Cotten M. Microtubule-independent motility and nuclear targeting of adenoviruses with fluorescently labeled genomes. J. Virol. 75 5 (2001) 2421-2434
14. Greber U.F., Willetts M., Webster P., and Helenius A. Stepwise dismantling of adenovirus 2 during entry into cells. Cell 75 3 (1993) 477-486
15. Greber U.F., Suomalainen M., Stidwill R.P., Boucke K., Ebersold M.W., and Helenius A. The role of the nuclear pore complex in adenovirus DNA entry. EMBO J. 16 19 (1997) 5998-6007
16. Hawkins L.K., and Hermiston T. Gene delivery from the E3 region of replicating human adenovirus: evaluation of the E3B region. Gene Ther. 8 15 (2001) 1142-1148
17. Hawkins L.K., and Hermiston T.W. Gene delivery from the E3 region of replicating human adenovirus: evaluation of the ADP region. Gene Ther. 8 15 (2001) 1132-1141
18. Hawkins L.K., Johnson L., Bauzon M., Nye J.A., Castro D., Kitzes G.A., Young M.D., Holt J.K., Trown P., and Hermiston T.W. Gene delivery from the E3 region of replicating human adenovirus: evaluation of the 6.7 K/gp19 K region. Gene Ther. 8 15 (2001) 1123-1131
19. He T.C., Zhou S., da Costa L.T., Yu J., Kinzler K.W., and Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc. Natl. Acad. Sci. U.S.A. 95 5 (1998) 2509-2514
20. Huang W.Y., Aramburu J., Douglas P.S., and Izumo S. Transgenic expression of green fluorescence protein can cause dilated cardiomyopathy. Nat. Med. 6 5 (2000) 482-483
21. Kelkar S.A., Pfister K.K., Crystal R.G., and Leopold P.L. Cytoplasmic dynein mediates adenovirus binding to microtubules. J. Virol. 78 18 (2004) 10122-10132
22. Korn R., and Horwitz M.S. Adenovirus DNA synthesis in vitro is inhibited by the virus-coded major core protein. Virology 150 2 (1986) 342-351
23. Le L.P., Everts M., Dmitriev I.P., Davydova J.G., Yamamoto M., and Curiel D.T. Fluorescently labeled adenovirus with pIX-EGFP for vector detection. Mol. Imaging 3 2 (2004) 105-116
24. Lee T.W., Blair G.E., and Matthews D.A. Adenovirus core protein VII contains distinct sequences that mediate targeting to the nucleus and nucleolus, and colocalization with human chromosomes. J. Gen. Virol. 84 Pt. 12 (2003) 3423-3428
25. Lee T.W., Lawrence F.J., Dauksaite V., Akusjarvi G., Blair G.E., and Matthews D.A. Precursor of human adenovirus core polypeptide Mu targets the nucleolus and modulates the expression of E2 proteins. J. Gen. Virol. 85 Pt. 1 (2004) 185-196
26. Lehmberg E., Traina J.A., Chakel J.A., Chang R.J., Parkman M., McCaman M.T., Murakami P.K., Lahidji V., Nelson J.W., Hancock W.S., Nestaas E., and Pungor Jr. E. Reversed-phase high-performance liquid chromatographic assay for the adenovirus type 5 proteome. J. Chromatogr., B, Biomed. Sci. Appl. 732 2 (1999) 411-423
27. Leopold P.L., Ferris B., Grinberg I., Worgall S., Hackett N.R., and Crystal R.G. Fluorescent virions: dynamic tracking of the pathway of adenoviral gene transfer vectors in living cells. Hum. Gene Ther. 9 3 (1998) 367-378
28. Liu H.S., Jan M.S., Chou C.K., Chen P.H., and Ke N.J. Is green fluorescent protein toxic to the living cells?. Biochem. Biophys. Res. Commun. 260 3 (1999) 712-717
29. Logan J., and Shenk T. Adenovirus tripartite leader sequence enhances translation of mRNAs late after infection. Proc. Natl. Acad. Sci. U.S.A. 81 12 (1984) 3655-3659
30. Matthews D.A. Adenovirus protein V induces redistribution of nucleolin and B23 from nucleolus to cytoplasm. J. Virol. 75 2 (2001) 1031-1038
31. Matthews D.A., and Russell W.C. Adenovirus core protein V is delivered by the invading virus to the nucleus of the infected cell and later in infection is associated with nucleoli. J. Gen. Virol. 79 Pt. 7 (1998) 1671-1675
32. Meulenbroek R.A., Sargent K.L., Lunde J., Jasmin B.J., and Parks R.J. Use of adenovirus protein IX (pIX) to display large polypeptides on the virion-generation of fluorescent virus through the incorporation of pIX-GFP. Mol. Ther. 9 4 (2004) 617-624
33. Mirza M.A., and Weber J. Structure of adenovirus chromatin. Biochim. Biophys. Acta 696 1 (1982) 76-86
34. Mittal S.K., McDermott M.R., Johnson D.C., Prevec L., and Graham F.L. Monitoring foreign gene expression by a human adenovirus-based vector using the firefly luciferase gene as a reporter. Virus Res. 28 1 (1993) 67-90
35. Miyazawa N., Leopold P.L., Hackett N.R., Ferris B., Worgall S., Falck-Pedersen E., and Crystal R.G. Fiber swap between adenovirus subgroups B and C alters intracellular trafficking of adenovirus gene transfer vectors. J. Virol. 73 7 (1999) 6056-6065
36. Nakanishi Y., Maeda K., Ohtsuki M., Hosokawa K., and Natori S. In vitro transcription of a chromatin-like complex of major core protein VII and DNA of adenovirus serotype 2. Biochem. Biophys. Res. Commun. 136 1 (1986) 86-93
37. Nakano M.Y., and Greber U.F. Quantitative microscopy of fluorescent adenovirus entry. J. Struct. Biol. 129 1 (2000) 57-68
38. Russell W.C. Update on adenovirus and its vectors. J. Gen. Virol. 81 Pt. 11 (2000) 2573-2604
39. Sheay W., Nelson S., Martinez I., Chu T.H., Bhatia S., and Dornburg R. Downstream insertion of the adenovirus tripartite leader sequence enhances expression in universal eukaryotic vectors. BioTechniques 15 5 (1993) 856-862
40. Sung M.T., Cao T.M., Lischwe M.A., and Coleman R.T. Molecular processing of adenovirus proteins. J. Biol. Chem. 258 13 (1983) 8266-8272
41. van Oostrum J., and Burnett R.M. Molecular composition of the adenovirus type 2 virion. J. Virol. 56 2 (1985) 439-448
42. Vayda M.E., and Flint S.J. Isolation and characterization of adenovirus core nucleoprotein subunits. J. Virol. 61 10 (1987) 3335-3339
43. Von Seggern D.J., Huang S., Fleck S.K., Stevenson S.C., and Nemerow G.R. Adenovirus vector pseudotyping in fiber-expressing cell lines: improved transduction of Epstein-Barr virus-transformed B cells. J. Virol. 74 1 (2000) 354-362
44. Wienhues U., Hosokawa K., Hoveler A., Siegmann B., and Doerfler W. A novel method for transfection and expression of reconstituted DNA-protein complexes in eukaryotic cells. DNA 6 1 (1987) 81-89
45. Xue Y., Johnson J.S., Ornelles D.A., Lieberman J., and Engel D.A. Adenovirus protein VII functions throughout early phase and interacts with cellular proteins SET and pp32. J. Virol. 79 4 (2005) 2474-2483
46. Yamamoto M., Davydova J., Wang M., Siegal G.P., Krasnykh V., Vickers S.M., and Curiel D.T. Infectivity enhanced, cyclooxygenase-2 promoter-based conditionally replicative adenovirus for pancreatic cancer. Gastroenterology 125 4 (2003) 1203-1218